Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib. (Q51749846)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 2007
edit
Language Label Description Also known as
English
Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.
scientific article published in June 2007

    Statements

    Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit